GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT0 million
Press Release

GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million

TAIPEI and SAN DIEGO, July 15, 2026 /PRNewswire/ — GEM Global Yield LLC SCS ("GEM") has executed a Share Purchase Agreement (the "SPA") with the existing shareholders of Taiwan-listed Senhwa Biosciences Inc. (TPEx: 6492), under which GEM has committed up to NT$500 million (approximately US$15.5 million) to purchase shares in the Company over the next […]

Read More
Radisson Hotel Group highlights strategic growth across Southeast Asia Pacific
Press Release

Radisson Hotel Group highlights strategic growth across Southeast Asia Pacific

BANGKOK and BRUSSELS, July 15, 2026 /PRNewswire/ — Across the region, Radisson Hotel Group continues to pursue a market-specific development strategy, matching the right brand and operating model to each destination and owner objective. This approach is supporting growth in established gateway cities, major leisure destinations and emerging markets, while strengthening the Group’s ability to serve […]

Read More
De Tomaso Advances Next-Generation V12 Programme with Italtecnica
Press Release

De Tomaso Advances Next-Generation V12 Programme with Italtecnica

HONG KONG and TURIN, Italy, July 15, 2026 /PRNewswire/ — OIO Group (NASDAQ: OIO) today announced its collaboration with Italtecnica Engineering on De Tomaso’s next-generation V12 programme, as prototype bench testing commences following the successful completion of the engine’s design and engineering phase. De Tomaso’s next-generation V12 is a clean-sheet, bespoke powertrain engineered exclusively for […]

Read More
Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development
Press Release

Insilico Medicine and Bora Pharmaceuticals Announce Strategic Alliance for AI-Driven Drug Discovery and Development

Combines Insilico’s Pharma.AI platform with Bora’s global development, manufacturing, quality, and commercialization capabilities to explore a next-generation drug innovation model CAMBRIDGE, Mass. and TAIPEI, July 15, 2026 /PRNewswire/ — Insilico Medicine ("Insilico"; HKEX: 3696), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, today announced a multi-target strategic alliance with Bora Pharmaceuticals Co., Ltd. ("Bora"; […]

Read More
The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses
Press Release

The University of Western Australia appoints SRM Technologies as Information Technology Partner for its India Branch Campuses

Admissions now open at https://bit.ly/4wBV333 for UWA India’s Mumbai and Chennai campuses, with scholarships available for eligible students. MELBOURNE, Australia, July 15, 2026 /PRNewswire/ — The University of Western Australia (UWA), a Global Top 100 university and founding member of Australia’s prestigious Group of Eight (Go8), has appointed SRM Technologies as its Information Technology partner for the establishment […]

Read More
Globe Bags Back-to-Back Recognition in TIME's World's Most Sustainable Companies, Remains Only Philippine Telco on Global List
Press Release

Globe Bags Back-to-Back Recognition in TIME's World's Most Sustainable Companies, Remains Only Philippine Telco on Global List

TAGUIG CITY, Philippines, July 15, 2026 /PRNewswire/ — For the second consecutive year, Globe has been recognized in TIME and Statista’s World’s Most Sustainable Companies 2026, becoming the only Philippine telecommunications company included in the global ranking and one of only two Philippine companies recognized this year, underscoring its commitment to responsible business practices and […]

Read More
Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint
Press Release

Kelun-Biotech Announces Phase III Study of Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First-Line Treatment for PD-L1-Negative Non-Squamous NSCLC Met Primary Endpoint

As a head-to-head Phase III trial comparing sac-TMT plus pembrolizumab with the first-line standard of care (immunotherapy plus chemotherapy), OptiTROP-Lung06 demonstrated the superiority of replacing conventional pemetrexed/platinum chemotherapy with sac-TMT, with significantly prolonged PFS and a positive OS trend compared with pembrolizumab plus pemetrexed and platinum-based chemotherapy. Focusing on the particularly challenging first-line treatment for […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.